Botswana vs Haiti: HIV/AIDS deaths averted by antiretroviral therapy
Botswana
9,751 deaths
in 2024
Haiti
8,513 deaths
in 2024
Botswana rank
25th
Haiti rank
27th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Botswana
- Haiti
How they compare
Botswana currently reports 9,751 deaths against 8,513 deaths in Haiti, a difference of 1,238 deaths.
That makes Botswana's figure about 1.1 times Haiti's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Haiti ahead.
Botswana ranks 25th and Haiti ranks 27th of 157 countries.
Botswana has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Botswana | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.78 deaths | 0 deaths | 14.78 deaths | Botswana |
| 2000s | 7,590 deaths | 1,003 deaths | 6,587 deaths | Botswana |
| 2010s | 14,708 deaths | 4,307 deaths | 10,401 deaths | Botswana |
| 2020s | 10,907 deaths | 8,123 deaths | 2,784 deaths | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Botswana or Haiti?
- Botswana, at 9,751 deaths against 8,513 deaths in Haiti as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Botswana and Haiti?
- 1,238 deaths, with Botswana ahead.
- How many years of comparable data are there for Botswana and Haiti?
- 35 years are reported by both, from 1990 to 2024.
- How do Botswana and Haiti rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Botswana ranks 25th and Haiti ranks 27th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.